Atharv Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 8:01 am

Quick Insight

Atharv Enterprises Ltd, a Non-Banking Financial Company, currently trades at a price of 3.49 with a market capitalization of 5.93 Cr. The company's P/E ratio stands at 29.6, reflecting investor optimism. However, with a low ROE of 0.95% and ROCE of 1.34%, there are concerns about the company's efficiency in generating returns. The negative operating profit margin of -265.38% raises red flags regarding operational performance. With a high proportion of public shareholding at 92.83% and minimal promoter holding at 7.17%, there may be questions about governance and control. The low P/BV ratio of 0.24x suggests undervaluation, but the ICR of 16.77x indicates good debt-servicing ability. Overall, investors should carefully assess operational efficiency and governance factors despite the seemingly attractive valuation metrics.

Competitors of Atharv Enterprises Ltd

All Competitor Stocks of Atharv Enterprises Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:05 pm

Below is a detailed analysis of the quarterly data for Atharv Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.26 Cr..
• For Expenses, as of Jun 2025, the value is 0.95 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.15 Cr. (Mar 2025) to 0.95 Cr., marking a decrease of 0.20 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.69 Cr.. The value appears strong and on an upward trend. It has increased from -1.15 Cr. (Mar 2025) to -0.69 Cr., marking an increase of 0.46 Cr..
• For OPM %, as of Jun 2025, the value is -265.38%. The value appears to be declining and may need further review. It has decreased from 0.00% (Mar 2025) to -265.38%, marking a decrease of 265.38%.
• For Other Income, as of Jun 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.24 Cr. (Mar 2025) to 0.77 Cr., marking a decrease of 0.47 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 0.08 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.02 Cr..
• For Tax %, as of Jun 2025, the value is 33.33%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 33.33%, marking an increase of 8.33%.
• For Net Profit, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.03. The value appears to be declining and may need further review. It has decreased from 0.04 (Mar 2025) to 0.03, marking a decrease of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:29 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:48 pm

Below is a detailed analysis of the balance sheet data for Atharv Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 3.05 Cr.. The value appears strong and on an upward trend. It has increased from 2.85 Cr. (Mar 2024) to 3.05 Cr., marking an increase of 0.20 Cr..
• For Borrowings, as of Mar 2025, the value is 0.18 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.27 Cr. (Mar 2024) to 0.18 Cr., marking a decrease of 0.09 Cr..
• For Other Liabilities, as of Mar 2025, the value is 15.86 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.57 Cr. (Mar 2024) to 15.86 Cr., marking an increase of 3.29 Cr..
• For Total Liabilities, as of Mar 2025, the value is 36.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.69 Cr. (Mar 2024) to 36.09 Cr., marking an increase of 3.40 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.29 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Mar 2024) to 0.29 Cr., marking a decrease of 0.15 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 6.58 Cr.. The value appears to be declining and may need further review. It has decreased from 8.24 Cr. (Mar 2024) to 6.58 Cr., marking a decrease of 1.66 Cr..
• For Other Assets, as of Mar 2025, the value is 29.22 Cr.. The value appears strong and on an upward trend. It has increased from 24.01 Cr. (Mar 2024) to 29.22 Cr., marking an increase of 5.21 Cr..
• For Total Assets, as of Mar 2025, the value is 36.09 Cr.. The value appears strong and on an upward trend. It has increased from 32.69 Cr. (Mar 2024) to 36.09 Cr., marking an increase of 3.40 Cr..

Notably, the Reserves (3.05 Cr.) exceed the Borrowings (0.18 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Atharv Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.11.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.11.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 3. It has increased from 0.13 (Mar 24) to 0.14, marking an increase of 0.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.79. It has increased from 11.68 (Mar 24) to 11.79, marking an increase of 0.11.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.79. It has increased from 11.68 (Mar 24) to 11.79, marking an increase of 0.11.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.15. It has decreased from 6.50 (Mar 24) to 0.15, marking a decrease of 6.35.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 2. It has increased from 0.17 (Mar 24) to 0.19, marking an increase of 0.02.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.16. This value is within the healthy range. It has increased from 0.15 (Mar 24) to 0.16, marking an increase of 0.01.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.15, marking an increase of 0.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 2. It has increased from 0.10 (Mar 24) to 0.11, marking an increase of 0.01.
• For PBDIT Margin (%), as of Mar 25, the value is 121.46. This value is within the healthy range. It has increased from 2.73 (Mar 24) to 121.46, marking an increase of 118.73.
• For PBIT Margin (%), as of Mar 25, the value is 103.60. This value exceeds the healthy maximum of 20. It has increased from 2.40 (Mar 24) to 103.60, marking an increase of 101.20.
• For PBT Margin (%), as of Mar 25, the value is 96.36. This value is within the healthy range. It has increased from 2.25 (Mar 24) to 96.36, marking an increase of 94.11.
• For Net Profit Margin (%), as of Mar 25, the value is 72.27. This value exceeds the healthy maximum of 10. It has increased from 1.67 (Mar 24) to 72.27, marking an increase of 70.60.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 15. It has increased from 0.93 (Mar 24) to 0.96, marking an increase of 0.03.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.36. This value is below the healthy minimum of 10. It has increased from 1.31 (Mar 24) to 1.36, marking an increase of 0.05.
• For Return On Assets (%), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 5. It has decreased from 0.56 (Mar 24) to 0.53, marking a decrease of 0.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.35 (Mar 24) to 0.01, marking a decrease of 0.34.
• For Current Ratio (X), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 1.5. It has decreased from 1.78 (Mar 24) to 0.80, marking a decrease of 0.98.
• For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.72 (Mar 24) to 0.77, marking a decrease of 0.95.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 16.77. This value is within the healthy range. It has decreased from 18.46 (Mar 24) to 16.77, marking a decrease of 1.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.98. This value is within the healthy range. It has decreased from 12.26 (Mar 24) to 10.98, marking a decrease of 1.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4.79. It has increased from 3.77 (Mar 24) to 4.79, marking an increase of 1.02.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 17.96. This value exceeds the healthy maximum of 3. It has increased from 0.34 (Mar 24) to 17.96, marking an increase of 17.62.
• For EV / EBITDA (X), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 12.46 (Mar 24) to 14.78, marking an increase of 2.32.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 18.56. This value exceeds the healthy maximum of 3. It has increased from 0.32 (Mar 24) to 18.56, marking an increase of 18.24.
• For Price / BV (X), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.24, marking an increase of 0.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 18.65. This value exceeds the healthy maximum of 3. It has increased from 0.32 (Mar 24) to 18.65, marking an increase of 18.33.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness